propranolol has been researched along with mianserin in 34 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 9 (26.47) | 18.7374 |
| 1990's | 7 (20.59) | 18.2507 |
| 2000's | 8 (23.53) | 29.6817 |
| 2010's | 10 (29.41) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Andrews, PR; Craik, DJ; Martin, JL | 1 |
| Foulon, C; Kung, HF; Kung, MP | 1 |
| Topliss, JG; Yoshida, F | 1 |
| Johans, C; Kinnunen, PK; Söderlund, T; Suomalainen, P | 1 |
| Ahlin, G; Artursson, P; Bergström, CA; Gustavsson, L; Karlsson, J; Larsson, R; Matsson, P; Norinder, U; Pedersen, JM | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Choi, SS; Contrera, JF; Hastings, KL; Kruhlak, NL; Sancilio, LF; Weaver, JL; Willard, JM | 1 |
| García-Mera, X; González-Díaz, H; Prado-Prado, FJ | 1 |
| Fisk, L; Greene, N; Naven, RT; Note, RR; Patel, ML; Pelletier, DJ | 1 |
| Glen, RC; Lowe, R; Mitchell, JB | 1 |
| Ekins, S; Williams, AJ; Xu, JJ | 1 |
| Bellera, CL; Bruno-Blanch, LE; Castro, EA; Duchowicz, PR; Goodarzi, M; Ortiz, EV; Pesce, G; Talevi, A | 1 |
| Caradonna, NP; Hallifax, D; Houston, JB; Turlizzi, E; Zanelli, U | 1 |
| Cantin, LD; Chen, H; Kenna, JG; Noeske, T; Stahl, S; Walker, CL; Warner, DJ | 1 |
| Bucki, A; Chrzanowska, A; Czopek, A; Drop, M; Głuch-Lutwin, M; Kołaczkowski, M; Partyka, A; Pawłowski, M; Pękala, E; Siwek, A; Struga, M; Wesołowska, A; Zagórska, A | 1 |
| Burgess, CD; Turner, P; Wadsworth, J | 1 |
| Fludder, JM; Leonard, BE | 1 |
| Badia, A; Sallés, J; Vila, E | 1 |
| Jenner, P; Marsden, CD; Stewart, BR | 1 |
| Alila, HW; Battista, PJ; Hansel, W; Rexroad, CE | 1 |
| Alexander, BS; Wood, MD | 1 |
| Battista, PJ; Condon, WA | 1 |
| Appia, F; Chariot, J; Pascaud, X; Rozé, C; Vaille, C | 1 |
| Ashton, D; Leysen, JE; Wauquier, A | 1 |
| Bódis, J; Hanf, V; Papenfuss, F; Schwarz, H; Tinneberg, HR; Török, A | 1 |
| Blier, P; de Montigny, C; Piñeyro, G; Weiss, M | 1 |
| Criscuolo, M; Ficarra, G; Genazzani, AR; Guo, AL; Nappi, RE; Petraglia, F; Salvestroni, C; Trentini, GP | 1 |
| Katayama, S; Kohno, H; Ohkubo, Y; Ohuchi, Y | 1 |
| Fujiseki, Y; Inagaki, C; Kinoshita, T; Okugawa, G; Omori, K; Suzukawa, J | 1 |
| Dimellis, D | 1 |
| Fuchs, C; Pashinian, A; Poyurovsky, M; Weizman, A; Weizman, R | 1 |
| Dellenbaugh, T; Hieber, R; Nelson, LA | 1 |
| Andrzejczak, D; Kocon, K; Zieba, R | 1 |
| Hamman, C; Hayes, M; Schmidt, DE; Wong, M | 1 |
2 trial(s) available for propranolol and mianserin
| Article | Year |
|---|---|
Cardiovascular responses to mianserin hydrochloride: a comparison with tricyclic antidepressant drugs.
Topics: Adult; Amitriptyline; Antidepressive Agents, Tricyclic; Bethanidine; Blood Pressure; Cardiovascular System; Clinical Trials as Topic; Clomipramine; Depression; Desipramine; Dibenzazepines; Double-Blind Method; Drug Interactions; Female; Guanethidine; Heart Rate; Humans; Hydralazine; Hypertension; Male; Mianserin; Propranolol | 1978 |
Low-dose mirtazapine: a new option in the treatment of antipsychotic-induced akathisia. A randomized, double-blind, placebo- and propranolol-controlled trial.
Topics: Adult; Akathisia, Drug-Induced; Analysis of Variance; Anti-Anxiety Agents; Antidepressive Agents, Tricyclic; Antipsychotic Agents; Dose-Response Relationship, Drug; Double-Blind Method; Female; Humans; Male; Mental Disorders; Mianserin; Middle Aged; Mirtazapine; Placebos; Propranolol; Prospective Studies; Treatment Outcome | 2006 |
32 other study(ies) available for propranolol and mianserin
| Article | Year |
|---|---|
Functional group contributions to drug-receptor interactions.
Topics: Animals; Calorimetry; Kinetics; Models, Biological; Protein Binding; Receptors, Cell Surface; Receptors, Drug; Structure-Activity Relationship | 1984 |
Synthesis of (R,S)-2'-trans-7-hydroxy-2-[N-n-propyl-N-(3'-iodo-2'- propenyl)-amino]tetralin (trans-7-OH-PIPAT): a new D3 dopamine receptor ligand.
Topics: Binding Sites; Dopamine Agents; Receptors, Dopamine; Receptors, Dopamine D2; Receptors, Dopamine D3; Salicylamides; Stereoisomerism; Tetrahydronaphthalenes | 1993 |
QSAR model for drug human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship | 2000 |
Surface activity profiling of drugs applied to the prediction of blood-brain barrier permeability.
Topics: Blood-Brain Barrier; Lipid Bilayers; Micelles; Permeability; Pharmaceutical Preparations; Structure-Activity Relationship; Surface Properties | 2004 |
Structural requirements for drug inhibition of the liver specific human organic cation transport protein 1.
Topics: Cell Line; Computer Simulation; Drug Design; Gene Expression Profiling; Humans; Hydrogen Bonding; Liver; Molecular Weight; Organic Cation Transporter 1; Pharmaceutical Preparations; Predictive Value of Tests; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Structure-Activity Relationship | 2008 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Development of a phospholipidosis database and predictive quantitative structure-activity relationship (QSAR) models.
Topics: | 2008 |
Multi-target spectral moment QSAR versus ANN for antiparasitic drugs against different parasite species.
Topics: Antiparasitic Agents; Molecular Structure; Neural Networks, Computer; Parasitic Diseases; Quantitative Structure-Activity Relationship; Species Specificity; Thermodynamics | 2010 |
Developing structure-activity relationships for the prediction of hepatotoxicity.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Humans; Structure-Activity Relationship; Tetracyclines; Thiophenes | 2010 |
Predicting phospholipidosis using machine learning.
Topics: Animals; Artificial Intelligence; Databases, Factual; Drug Discovery; Humans; Lipidoses; Models, Biological; Phospholipids; Support Vector Machine | 2010 |
A predictive ligand-based Bayesian model for human drug-induced liver injury.
Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands | 2010 |
Prediction of drug intestinal absorption by new linear and non-linear QSPR.
Topics: Humans; Intestinal Absorption; Linear Models; Molecular Conformation; Nonlinear Dynamics; Permeability; Pharmaceutical Preparations; Probability; Quantitative Structure-Activity Relationship; Thermodynamics | 2011 |
Comparison of cryopreserved HepaRG cells with cryopreserved human hepatocytes for prediction of clearance for 26 drugs.
Topics: Cell Line, Tumor; Cryopreservation; Female; Hepatocytes; Humans; Male; Metabolic Clearance Rate; Pharmaceutical Preparations; Predictive Value of Tests | 2012 |
Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Humans; Quantitative Structure-Activity Relationship | 2012 |
Novel multitarget 5-arylidenehydantoins with arylpiperazinealkyl fragment: Pharmacological evaluation and investigation of cytotoxicity and metabolic stability.
Topics: Animals; Antidepressive Agents; Depression; Disease Models, Animal; Humans; Receptors, Serotonin; Structure-Activity Relationship | 2019 |
The effects of amitriptyline, mianserin, phenoxybenzamine and propranolol on the release of noradrealine in the rat brain in vivo.
Topics: Amitriptyline; Animals; Brain; Dibenzazepines; Male; Mianserin; Norepinephrine; Normetanephrine; Phenoxybenzamine; Propranolol; Rats; Time Factors | 1979 |
Effects of chronic antidepressant treatment on alpha 1- and alpha 2-adrenoceptors in the rat anococcygeus muscle.
Topics: Animals; Antidepressive Agents; Cocaine; Desipramine; Electric Stimulation; Male; Mianserin; Muscle Contraction; Muscles; Nomifensine; Normetanephrine; Nortriptyline; Phenylephrine; Propranolol; Rats; Rats, Inbred Strains; Receptors, Adrenergic, alpha; Xylazine | 1990 |
Induction of purposeless chewing behaviour in rats by 5-HT agonist drugs.
Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Animals; Behavior, Animal; Male; Methiothepin; Methoxydimethyltryptamines; Mianserin; Parasympatholytics; Piperazines; Propranolol; Quipazine; Rats; Rats, Inbred Strains; Receptors, Serotonin; Spiperone; Tetrahydronaphthalenes | 1989 |
The effects of platelet-activating factor and platelet-derived compounds on bovine luteal cell progesterone production.
Topics: Animals; Blood Platelets; Cattle; Chromatography, High Pressure Liquid; Corpus Luteum; Epidermal Growth Factor; Female; Indomethacin; Luteinizing Hormone; Mianserin; Platelet Activating Factor; Platelet Aggregation; Platelet-Derived Growth Factor; Progesterone; Propranolol; Serotonin | 1989 |
Stereoselective blockade of central [3H]5-hydroxytryptamine binding to multiple sites (5-HT1A, 5-HT1B and 5-HT1C) by mianserin and propranolol.
Topics: Animals; Brain Chemistry; Corpus Striatum; In Vitro Techniques; Ketanserin; Male; Membranes; Mianserin; Propranolol; Rats; Rats, Inbred Strains; Receptors, Serotonin; Serotonin; Stereoisomerism | 1987 |
Serotonin-induced stimulation of progesterone production by cow luteal cells in vitro.
Topics: Amines; Animals; Cattle; Cells, Cultured; Corpus Luteum; Female; Isoproterenol; Luteinizing Hormone; Mianserin; Progesterone; Propranolol; Serotonin; Stimulation, Chemical | 1986 |
Clonidine inhibition of pancreatic secretion in rats: a possible central site of action.
Topics: Animals; Clonidine; Deoxyglucose; Gastric Juice; Male; Mianserin; Pancreas; Prazosin; Propranolol; Rats; Rats, Inbred Strains; Receptors, Adrenergic, alpha; Yohimbine | 1981 |
Neurotransmitters and receptor binding in amygdaloid kindled rats: serotonergic and noradrenergic modulatory effects.
Topics: 5-Hydroxytryptophan; Amygdala; Animals; Brain; Clonidine; Dexetimide; Electric Stimulation; Male; Mianserin; Muscimol; Propranolol; Rats; Seizures; Serotonin Antagonists | 1980 |
Serotonin induces progesterone release from human granulosa cells in a superfused granulosa cell system.
Topics: Adult; Cells, Cultured; Female; Granulosa Cells; Humans; Mianserin; Progesterone; Propranolol; Secretory Rate; Serotonin | 1993 |
Autoregulatory properties of dorsal raphe 5-HT neurons: possible role of electrotonic coupling and 5-HT1D receptors in the rat brain.
Topics: Action Potentials; Animals; Dendrites; Electric Stimulation; Electrophysiology; Extracellular Space; Indoles; Male; Mianserin; Piperazines; Propranolol; Raphe Nuclei; Rats; Rats, Sprague-Dawley; Receptors, Serotonin; Serotonin; Serotonin Antagonists; Serotonin Receptor Agonists; Synapses | 1996 |
Adrenergic and serotoninergic receptors mediate the immunological activation of corticosterone secretion in male rats.
Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Animals; Corticosterone; Immune System; Lipopolysaccharides; Male; Mianserin; Pindolol; Prazosin; Propranolol; Rats; Rats, Wistar; Receptors, Adrenergic; Receptors, Serotonin; Serotonin Antagonists | 1996 |
Possible neural mechanisms involved in footshock stress-induced enhancement of exploratory behavior in mice.
Topics: Animals; Atropine; Central Nervous System; Diazepam; Dizocilpine Maleate; Electric Stimulation; Exploratory Behavior; Haloperidol; Male; Mianserin; Mice; Naltrexone; Phentolamine; Propranolol; Stress, Physiological | 1999 |
Long-term treatment with antidepressants increases glucocorticoid receptor binding and gene expression in cultured rat hippocampal neurones.
Topics: Amitriptyline; Animals; Antidepressive Agents, Tricyclic; Cells, Cultured; Desipramine; Dexamethasone; Gene Expression Regulation; Haloperidol; Hippocampus; Ketanserin; Mianserin; Neurons; Paroxetine; Phentolamine; Propranolol; Radioligand Assay; Rats; Receptors, Glucocorticoid; Receptors, Mineralocorticoid; RNA, Messenger; Sulpiride; Transcription, Genetic; Tritium | 1999 |
Serotonin syndrome produced by a combination of venlafaxine and mirtazapine.
Topics: Adrenergic beta-Antagonists; Adult; Antidepressive Agents, Tricyclic; Cyclohexanols; Drug Therapy, Combination; Female; Humans; Lorazepam; Mianserin; Mirtazapine; Propranolol; Selective Serotonin Reuptake Inhibitors; Serotonin Syndrome; Venlafaxine Hydrochloride | 2002 |
Role of mirtazapine in the treatment of antipsychotic-induced akathisia.
Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Akathisia, Drug-Induced; Antipsychotic Agents; Clinical Trials as Topic; Humans; Mianserin; Mirtazapine; Propranolol; Receptors, Serotonin; Serotonin Antagonists | 2008 |
Influence of mirtazapine on the hypotensive activity of enalapril and propranolol in spontaneously hypertensive rats.
Topics: Adrenergic alpha-Antagonists; Animals; Antidepressive Agents, Tricyclic; Antihypertensive Agents; Dose-Response Relationship, Drug; Drug Interactions; Enalapril; Hypertension; Injections, Intraperitoneal; Male; Mianserin; Mirtazapine; Propranolol; Rats; Rats, Inbred SHR | 2008 |
The use of ammonium hydroxide as an additive in supercritical fluid chromatography for achiral and chiral separations and purifications of small, basic medicinal molecules.
Topics: Ammonium Hydroxide; Chromatography, Supercritical Fluid; Econazole; Flavones; Hydrogen-Ion Concentration; Hydroxides; Methanol; Mianserin; Organic Chemicals; Pharmaceutical Preparations; Propranolol; Reproducibility of Results; Stereoisomerism | 2011 |